• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过DNA检测对生化检测确定的亨特综合征携带者状态进行重新评估。

Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing.

作者信息

Timms K M, Edwards F J, Belmont J W, Yates J R, Gibbs R A

机构信息

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

J Med Genet. 1998 Aug;35(8):646-9. doi: 10.1136/jmg.35.8.646.

DOI:10.1136/jmg.35.8.646
PMID:9719370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1051389/
Abstract

Deficiency of iduronate-2-sulphatase (IDS) results in the X linked recessive lysosomal storage disorder Hunter syndrome. Determination of carrier status in families affected by this disorder has been performed using a variety of enzymatic tests. None of these tests has proved to be 100% effective at identifying carriers. The aim of this study was to perform carrier testing in a family affected by the disorder, where testing was complicated by the fact that no surviving affected subjects were available for study. Direct dye primer sequencing of PCR products was used to identify mixed bases in an obligate carrier. Two mixed bases were observed within exon VIII. The first base change (T-->A) at nucleotide position 1150 results in a missense mutation (H342Q), while the second base change (G-->T) at nucleotide position 1151 results in a nonsense mutation (G343X). Four additional female family members were screened for the same mutation. Using this approach it is possible to provide unambiguous information about a subject's carrier status and, unlike biochemical testing, this approach will be equally effective when applied to families with the mild form of this disorder.

摘要

艾杜糖醛酸-2-硫酸酯酶(IDS)缺乏会导致X连锁隐性溶酶体贮积症——亨特综合征。受该疾病影响的家庭中,已使用多种酶学检测方法来确定携带者状态。然而,这些检测方法均未被证明在识别携带者方面能达到100%的有效性。本研究的目的是在一个受该疾病影响的家庭中进行携带者检测,由于没有存活的患病个体可供研究,使得检测变得复杂。采用PCR产物的直接染料引物测序法来鉴定一名确定的携带者中的混合碱基。在外显子VIII内观察到两个混合碱基。核苷酸位置1150处的第一个碱基变化(T→A)导致错义突变(H342Q),而核苷酸位置1151处的第二个碱基变化(G→T)导致无义突变(G343X)。对另外四名女性家庭成员进行了相同突变的筛查。使用这种方法可以提供关于个体携带者状态的明确信息,并且与生化检测不同,当应用于患有该疾病轻度形式的家庭时,这种方法同样有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa2/1051389/853daa42c2e5/jmedgene00237-0032-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa2/1051389/853daa42c2e5/jmedgene00237-0032-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa2/1051389/853daa42c2e5/jmedgene00237-0032-a.jpg

相似文献

1
Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing.通过DNA检测对生化检测确定的亨特综合征携带者状态进行重新评估。
J Med Genet. 1998 Aug;35(8):646-9. doi: 10.1136/jmg.35.8.646.
2
Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).亨特综合征(黏多糖贮积症II型)患者中艾杜糖醛酸-2-硫酸酯酶(IDS)基因的突变
Hum Mutat. 1994;4(2):128-31. doi: 10.1002/humu.1380040206.
3
A novel iduronate 2-sulfatase mutation in a Chinese family with mucopolysaccharidosis type II.一个中国黏多糖贮积症 II 型家系中新型艾杜糖-2-硫酸酯酶基因突变。
World J Pediatr. 2012 Aug;8(3):281-3. doi: 10.1007/s12519-012-0357-1. Epub 2012 May 23.
4
Identification of 9 novel IDS gene mutations in 19 unrelated Hunter syndrome (mucopolysaccharidosis Type II) patients. Mutations in brief no. 202. Online.在19名非相关亨特综合征(II型粘多糖贮积症)患者中鉴定出9种新的IDS基因突变。简编编号202中的突变。在线版。
Hum Mutat. 1998;12(6):433. doi: 10.1002/(sici)1098-1004(1998)12:6<433::aid-humu12>3.0.co;2-m.
5
[Detection of a new mutation (T1140C)in a Chinese Guangdong patient with hunter syndrome].
Yi Chuan. 2006 May;28(5):521-4.
6
Prenatal diagnosis and carrier detection in mucopolysaccharidosis type II by mutation analysis. A 47,XXY male heterozygous for a missense point mutation.通过突变分析进行II型黏多糖贮积症的产前诊断和携带者检测。一名47,XXY男性,存在错义点突变的杂合子。
Prenat Diagn. 1994 Sep;14(9):777-80. doi: 10.1002/pd.1970140902.
7
Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.台湾地区亨特综合征(黏多糖贮积症Ⅱ型)的检测:黏多糖贮积症Ⅱ型患者及携带者艾杜糖醛酸-2-硫酸酯酶基因缺陷的生化及连锁研究
Clin Chim Acta. 2006 Jul 15;369(1):29-34. doi: 10.1016/j.cca.2006.01.001. Epub 2006 Feb 9.
8
Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene.II型黏多糖贮积症(亨特氏病)的中间型:艾杜糖醛酸硫酸酯酶基因中的C1327突变为T
Biochem Biophys Res Commun. 1992 Mar 16;183(2):809-13. doi: 10.1016/0006-291x(92)90555-y.
9
Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.将分子分析扩展到艾杜糖-2-硫酸酯酶基因的启动子区域,揭示了编码序列正常的黏多糖贮积症 II 型患者的基因组改变。
Gene. 2013 Sep 10;526(2):150-4. doi: 10.1016/j.gene.2013.05.007. Epub 2013 May 21.
10
Molecular analysis of patients with Hunter syndrome: implication of a region prone to structural alterations within the IDS gene.亨特综合征患者的分子分析:IDS基因内一个易于发生结构改变区域的意义。
Hum Mol Genet. 1992 Jun;1(3):195-8. doi: 10.1093/hmg/1.3.195.

本文引用的文献

1
DNA deletion confined to the iduronate-2-sulfatase promoter abolishes IDS gene expression.局限于艾杜糖醛酸-2-硫酸酯酶启动子的DNA缺失消除了IDS基因的表达。
Hum Mutat. 1998;11(2):121-6. doi: 10.1002/(SICI)1098-1004(1998)11:2<121::AID-HUMU4>3.0.CO;2-M.
2
The extent of genetic variation in the CCR5 gene.CCR5基因的遗传变异程度。
Nat Genet. 1997 Jul;16(3):221-2. doi: 10.1038/ng0797-221.
3
Mucopolysaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene.II型黏多糖贮积症(亨特综合征):艾杜糖醛酸-2-硫酸酯酶基因中的突变“热点”
Am J Hum Genet. 1996 Dec;59(6):1202-9.
4
130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus.130千碱基对的DNA序列揭示了两个新基因以及人艾杜糖醛酸-2-硫酸酯酶基因座远端的一个区域重复。
Genome Res. 1995 Aug;5(1):71-8. doi: 10.1101/gr.5.1.71.
5
Electrophoretically uniform fluorescent dyes for automated DNA sequencing.用于自动DNA测序的电泳均匀荧光染料。
Science. 1996 Mar 8;271(5254):1420-2. doi: 10.1126/science.271.5254.1420.
6
Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene.艾杜糖醛酸硫酸酯酶(IDS)基因编码序列组织结构的测定。
Hum Mol Genet. 1993 Jan;2(1):5-10. doi: 10.1093/hmg/2.1.5.
7
Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene.II型黏多糖贮积症的分子基础:艾杜糖醛酸-2-硫酸酯酶基因突变
Hum Mutat. 1993;2(6):435-42. doi: 10.1002/humu.1380020603.
8
An improved assay for iduronate 2-sulphate sulphatase in serum and its use in the detection of carriers of the Hunter syndrome.血清中艾杜糖醛酸2-硫酸酯酶的改良检测方法及其在亨特综合征携带者检测中的应用。
Clin Chim Acta. 1981 Apr 27;112(1):107-12. doi: 10.1016/0009-8981(81)90274-6.
9
The use of fructose 1-phosphate to detect Hunter heterozygotes in fibroblast cultures from high-risk carriers.使用1-磷酸果糖检测高危携带者成纤维细胞培养物中的亨特杂合子。
Hum Genet. 1984;66(2-3):212-6. doi: 10.1007/BF00286603.
10
Heterozygote detection in Hunter syndrome.亨特综合征的杂合子检测
Am J Med Genet. 1984 Mar;17(3):661-5. doi: 10.1002/ajmg.1320170317.